{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T07:07:45Z","timestamp":1788937665650,"version":"build-2803163510"},"reference-count":27,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"DOI":"10.1111\/dom.71317","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T06:59:45Z","timestamp":1788937185000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond Weight Loss: The Challenge of Stopping Obesity Management Medications"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8978-9359","authenticated-orcid":false,"given":"Mohammad","family":"Kermansaravi","sequence":"first","affiliation":[{"name":"Department of Surgery, Minimally Invasive Surgery Research Center, Division of Minimally Invasive and Bariatric Surgery, Hazrat\u2010e Rasool Hospital Iran University of Medical Sciences  Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8779-3055","authenticated-orcid":false,"given":"Ricardo V.","family":"Cohen","sequence":"additional","affiliation":[{"name":"The Center for the Treatment of Obesity and Diabetes Hospital Alemao Oswaldo Cruz  Sao Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"issue":"11","key":"e_1_2_1_7_2_1","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once\u2010Weekly Semaglutide in Adults With Overweight or Obesity","volume":"384","author":"Wilding J. P. H.","year":"2021","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"e_1_2_1_7_3_1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jama.2023.24945","article-title":"Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT\u20104 Randomized Clinical Trial","volume":"331","author":"Aronne L. J.","year":"2024","journal-title":"Journal of the American Medical Association"},{"issue":"3","key":"e_1_2_1_7_4_1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/joim.12012","article-title":"Review of the Key Results From the Swedish Obese Subjects (SOS) Trial \u2010 a Prospective Controlled Intervention Study of Bariatric Surgery","volume":"273","author":"Sj\u00f6str\u00f6m L.","year":"2013","journal-title":"Journal of Internal Medicine"},{"issue":"5","key":"e_1_2_1_7_5_1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1001\/jama.2025.24288","article-title":"World Health Organization Guideline on the Use and Indications of Glucagon\u2010Like Peptide\u20101 Therapies for the Treatment of Obesity in Adults","volume":"335","author":"Celletti F.","year":"2026","journal-title":"Journal of the American Medical Association"},{"issue":"27","key":"e_1_2_1_7_6_1","doi-asserted-by":"crossref","first-page":"E797","DOI":"10.1503\/cmaj.250502","article-title":"Pharmacotherapy for Obesity Management in Adults: 2025 Clinical Practice Guideline Update","volume":"197","author":"Pedersen S. D.","year":"2025","journal-title":"CMAJ"},{"issue":"17","key":"e_1_2_1_7_7_1","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1105816","article-title":"Long\u2010Term Persistence of Hormonal Adaptations to Weight Loss","volume":"365","author":"Sumithran P.","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"e_1_2_1_7_8_1","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1111\/dom.70004","article-title":"Real\u2010World Titration, Persistence & Weight Loss of Semaglutide and Tirzepatide in an Academic Obesity Clinic","volume":"27","author":"Samuels J. M.","year":"2025","journal-title":"Diabetes, Obesity & Metabolism"},{"issue":"1","key":"e_1_2_1_7_9_1","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12916-025-04200-0","article-title":"Trajectory of the Body Weight After Drug Discontinuation in the Treatment of Anti\u2010Obesity Medications","volume":"23","author":"Wu H.","year":"2025","journal-title":"BMC Medicine"},{"issue":"8","key":"e_1_2_1_7_10_1","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.14725","article-title":"Weight Regain and Cardiometabolic Effects After Withdrawal of Semaglutide: The STEP 1 Trial Extension","volume":"24","author":"Wilding J. P. H.","year":"2022","journal-title":"Diabetes, Obesity & Metabolism"},{"key":"e_1_2_1_7_11_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2026.103796","article-title":"Trajectory of Weight Regain After Cessation of GLP\u20101 Receptor Agonists: A Systematic Review and Nonlinear Meta\u2010Regression","volume":"93","author":"Budini B.","year":"2026","journal-title":"EClinicalMedicine"},{"key":"e_1_2_1_7_12_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103680","article-title":"Metabolic Rebound After GLP\u20101 Receptor Agonist Discontinuation: A Systematic Review and Meta\u2010Analysis","volume":"90","author":"Tzang C. C.","year":"2025","journal-title":"EClinicalMedicine"},{"issue":"6","key":"e_1_2_1_7_13_1","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1111\/dom.70660","article-title":"Obesity Treatments and Weight Changes in Clinical Practice After Discontinuation of Semaglutide or Tirzepatide","volume":"28","author":"Gasoyan H.","year":"2026","journal-title":"Diabetes, Obesity & Metabolism"},{"issue":"7","key":"e_1_2_1_7_14_1","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/s41591-024-02996-7","article-title":"Long\u2010Term Weight Loss Effects of Semaglutide in Obesity Without Diabetes in the SELECT Trial","volume":"30","author":"Ryan D. H.","year":"2024","journal-title":"Nature Medicine"},{"key":"e_1_2_1_7_15_1","unstructured":"US Food and Drug Administration \u201cFDA Approves First New Molecular Entity Under National Priority Voucher Program [Press Release] \u201d Silver Spring MD: FDA; April 1 2026."},{"issue":"18","key":"e_1_2_1_7_16_1","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1056\/NEJMoa2511774","article-title":"Orforglipron, an Oral Small\u2010Molecule GLP\u20101 Receptor Agonist for Obesity Treatment","volume":"393","author":"Wharton S.","year":"2025","journal-title":"New England Journal of Medicine"},{"issue":"10522","key":"e_1_2_1_7_17_1","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1016\/S0140-6736(25)02165-8","article-title":"Orforglipron, an Oral Small\u2010Molecule GLP\u20101 Receptor Agonist, for the Treatment of Obesity in People With Type 2 Diabetes (ATTAIN\u20102): A Phase 3, Double\u2010Blind, Randomised, Multicentre, Placebo\u2010Controlled Trial","volume":"406","author":"Horn D. B.","year":"2026","journal-title":"Lancet"},{"issue":"3","key":"e_1_2_1_7_18_1","doi-asserted-by":"crossref","DOI":"10.3390\/biom15030408","article-title":"Weight Reduction With GLP\u20101 Agonists and Paths for Discontinuation While Maintaining Weight Loss","volume":"15","author":"Reiss A. B.","year":"2025","journal-title":"Biomolecules"},{"issue":"10545","key":"e_1_2_1_7_19_1","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/S0140-6736(26)00656-2","article-title":"Tirzepatide for Maintenance of Bodyweight Reduction in People With Obesity in the USA (SURMOUNT\u2010MAINTAIN): A Multicentre, Double\u2010Blind, Randomised, Placebo\u2010Controlled Trial","volume":"407","author":"Horn D. B.","year":"2026","journal-title":"Lancet"},{"issue":"7","key":"e_1_2_1_7_20_1","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/s41591-026-04386-7","article-title":"Orforglipron for Maintenance of Body Weight Reduction: The Double\u2010Blind, Randomized Phase 3b ATTAIN\u2010MAINTAIN Trial","volume":"32","author":"Aronne L. J.","year":"2026","journal-title":"Nature Medicine"},{"issue":"4","key":"e_1_2_1_7_21_1","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1111\/dom.16229","article-title":"Alternative Dosing Regimens of GLP\u20101 Receptor Agonists May Reduce Costs and Maintain Weight Loss Efficacy","volume":"27","author":"Cengiz A.","year":"2025","journal-title":"Diabetes, Obesity & Metabolism"},{"issue":"1","key":"e_1_2_1_7_22_1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/oby.70137","article-title":"Reduced\u2010Frequency GLP1 Therapy Maintains Weight, Body Composition, and Metabolic Syndrome Improvements: A Case Series","volume":"34","author":"Wong M.","year":"2026","journal-title":"Obesity (Silver Spring)"},{"issue":"9","key":"e_1_2_1_7_23_1","doi-asserted-by":"crossref","first-page":"e250083","DOI":"10.57264\/cer-2025-0083","article-title":"Affordable Access to GLP\u20101 Obesity Medications: Strategies to Guide Market Action and Policy Solutions in the US","volume":"14","author":"Pearson S. D.","year":"2025","journal-title":"Journal of Comparative Effectiveness Research"},{"issue":"1","key":"e_1_2_1_7_24_1","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.70167","article-title":"iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025","volume":"17","author":"Anker S. D.","year":"2026","journal-title":"Journal of Cachexia, Sarcopenia and Muscle"},{"issue":"4","key":"e_1_2_1_7_25_1","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/oby.70100","article-title":"Comparative Efficacy of Metabolic\/Bariatric Surgery Versus GLP\u20101 Receptor Agonists: A Network Meta\u2010Analysis of Randomized Controlled Trials","volume":"34","author":"Sabatella L.","year":"2026","journal-title":"Obesity (Silver Spring)"},{"issue":"8","key":"e_1_2_1_7_26_1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.eprac.2024.05.005","article-title":"Switching to Tirzepatide 5 mg From Glucagon\u2010Like Peptide\u20101 Receptor Agonists: Clinical Expectations in the First 12\u2009Weeks of Treatment","volume":"30","author":"Jabbour S.","year":"2024","journal-title":"Endocrine Practice"},{"issue":"3","key":"e_1_2_1_7_27_1","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.surg.2023.07.027","article-title":"Outcome Comparison Between Primary and Revisional Bariatric Surgery: A Propensity\u2010Matched Analysis","volume":"175","author":"Giannopoulos S.","year":"2024","journal-title":"Surgery"},{"issue":"4","key":"e_1_2_1_7_28_1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/oby.70164","article-title":"Joint TOS\/OMA\/OAC Expert Guidance Statement on the Pharmacological Management of United States Adults With Overweight or Obesity Using the GRADE Approach","volume":"34","author":"Alexander L.","year":"2026","journal-title":"Obesity (Silver Spring)"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.71317","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dom.71317","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.71317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T06:59:49Z","timestamp":1788937189000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/10.1111\/dom.71317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":27,"alternative-id":["10.1111\/dom.71317"],"URL":"https:\/\/doi.org\/10.1111\/dom.71317","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"2026-08-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"dom.71317"}}